
|Articles|July 31, 2017
Schulman IRB Launches Central Neurology Review Service
Advertisement
Schulman IRB-an industry IRB in customer service and technology-announced the launch of its Central Neurology Review (CNR) service.
Through its partnership with the National Biomedical Research Ethics Council (NBREC), a 501(c) non-profit, Schulman developed CNR to assist research institutions and biopharma and device companies.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Life Sciences Can’t Afford Fragmented Data and Disconnected Teams
2
ACT Brief: Patient Preferences in Remote Trials, Sanofi’s Neurology and Immunology Deals, and AI-Driven Biomarkers in Oncology
3
FDA Approves GSK’s Exdensur for Severe Asthma Based on SWIFT Phase III Data
4
Rethinking Operational Models to Reduce Site Burden in 2026
5




